001360653 000__ 02550cam\\2200601\i\4500
001360653 001__ 1360653
001360653 003__ OCoLC
001360653 005__ 20210812132317.0
001360653 007__ he\bmb024bbca
001360653 008__ 181109s2018\\\\dcu\\\\\bb\\\f000\0\eng\c
001360653 019__ $$a1225634133
001360653 035__ $$a(OCoLC)1062363418
001360653 040__ $$aGPO$$beng$$erda$$cGPO$$dOCLCF$$dVDB$$dOCLCO$$dSPI$$dISE
001360653 042__ $$apcc
001360653 043__ $$an-us---
001360653 049__ $$aISEA
001360653 074__ $$a1008-D (MF)
001360653 0860_ $$aY 1.1/8:115-726
001360653 1101_ $$aUnited States.$$bCongress.$$bHouse.$$bCommittee on Energy and Commerce,$$eauthor.
001360653 24510 $$aMedicaid Pharmaceutical Home Act of 2018 :$$breport together with additional views (to accompany H.R. 5808) (including cost estimate of the Congressional Budget Office).
001360653 264_1 $$a[Washington, D.C.] :$$b[U.S. Government Publishing Office],$$c[2018]
001360653 300__ $$a36 pages ;$$c24 cm.
001360653 336__ $$atext$$btxt$$2rdacontent
001360653 337__ $$amicroform$$bh$$2rdamedia
001360653 338__ $$amicrofiche$$bhe$$2rdacarrier
001360653 4901_ $$aReport / 115th Congress, 2d session, House of Representatives ;$$v115-726
001360653 500__ $$aTitle from caption.
001360653 500__ $$a"June 12, 2018."
001360653 500__ $$aShipping list no.: 2018-00192-M.
001360653 504__ $$aIncludes bibliographical references.
001360653 533__ $$aMicrofiche.$$b[Washington, D.C.] :$$cU.S. Government Printing Office,$$d[2018]$$e1 microfiche : negative.
001360653 61010 $$aUnited States.$$tSocial Security Act.
001360653 61010 $$aUnited States.$$bFood and Drug Administration$$xRules and practice.
001360653 61017 $$aUnited States.$$bFood and Drug Administration.$$2fast$$0(OCoLC)fst00549734
001360653 63007 $$aSocial Security Act (United States)$$2fast$$0(OCoLC)fst01356645
001360653 650_0 $$aMedicaid.
001360653 650_0 $$aMedicare.
001360653 650_0 $$aDrugs$$xPrescribing$$zUnited States$$xManagement.
001360653 650_0 $$aOpioid abuse$$xTreatment$$zUnited States$$xCosts.
001360653 650_0 $$aDrug development$$xGovernment policy$$zUnited States.
001360653 650_0 $$aDrugs$$xGeneric substitution$$xGovernment policy$$zUnited States.
001360653 650_7 $$aMedicaid.$$2fast$$0(OCoLC)fst01013657
001360653 650_7 $$aMedicare.$$2fast$$0(OCoLC)fst01014815
001360653 651_7 $$aUnited States.$$2fast$$0(OCoLC)fst01204155
001360653 655_7 $$aLegislative materials.$$2fast$$0(OCoLC)fst01774285
001360653 655_7 $$aRules.$$2fast$$0(OCoLC)fst01423857
001360653 655_7 $$aLegislative materials.$$2lcgft
001360653 77608 $$iPrint version:$$aUnited States. Congress. House. Committee on Energy and Commerce.$$tMedicaid Pharmaceutical Home Act of 2018$$w(OCoLC)1042086032
001360653 77608 $$iOnline version:$$aUnited States. Congress. House. Committee on Energy and Commerce.$$tMedicaid Pharmaceutical Home Act of 2018$$w(OCoLC)1042074892
001360653 8101_ $$aUnited States.$$bCongress.$$bHouse.$$tReport ;$$v115-726.
001360653 852__ $$bdfich
001360653 852__ $$bedoc$$hY 1.1/8:115-726
001360653 85640 $$uhttps://purl.fdlp.gov/GPO/gpo94185
001360653 909CO $$ooai:library.usi.edu:1360653$$pGLOBAL_SET
001360653 980__ $$aBIB
001360653 980__ $$aEGOV
001360653 982__ $$aGovernment E-Resource
001360653 983__ $$aOnline
001360653 994__ $$aC0$$bISE